...
Mounjaro's launch has brought cheer to Indian patients who had been relying on friends, family or suppliers abroad to get hold of these drugs.
Amar Vennapusa, a bariatric surgeon, fills a syringe with Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss, at his health clinic in Hyderabad, India, Apr.14, 2025.
Credit: Reuters/Almaas Masood
